Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease – A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA)

References

• Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4(1):31. doi:10.1186/1477-7525-4-3116719899
   PubMed Web of Science ®Google Scholar
• Loddenkemper R, Gibson GJ, Sibille Y. The burden of lung disease in Europe: why a European white book on lung disease? Eur Respir J. 2003;22(6):869. (). doi:10.1183/09031936.03.0010780314680068
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233–239. doi:10.7326/0003-4819-142-4-200502150-0000515710956
   PubMed Web of Science ®Google Scholar
• Ferguson GT. Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence? Respir Med. 2011;105(9):1268–1274. doi:10.1016/j.rmed.2011.02.00521353516
   PubMed Web of Science ®Google Scholar
• GOLD. From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2017; 2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/2017. Official homepage for Global Strategy for the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
   Google Scholar
• Stuart BC, Simoni-Wastila L, Zuckerman IH, et al. Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother. 2010;8(5):441–453. doi:10.1016/j.amjopharm.2010.10.00221335297
   PubMedGoogle Scholar
• [Läkemedelsverket]. SMPA. Chronic obstructive pulmonary disease - treatment recommendations [Swedish: kroniskt Obstruktiv Lungsjukdom - behandlingsrekommendationer]; 2015 Available from: https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/Kroniskt_obstruktiv_lungsjukdom_KOL_behandlingsrekommendation.pdf2015.
   Google Scholar
• Melani AS. Long-acting muscarinic antagonists. Expert Rev Clin Pharmacol. 2015;8(4):479–501. doi:10.1586/17512433.2015.105815426109098
   PubMed Web of Science ®Google Scholar
• Oates GR, Hamby BW, Stepanikova I, et al. Social determinants of adherence to pulmonary rehabilitation for chronic obstructive pulmonary disease. Copd. 2017;14(6):610–617. doi:10.1080/15412555.2017.137907029020525
   PubMedGoogle Scholar
• Tottenborg SS, Lange P, Johnsen SP, Nielsen H, Ingebrigtsen TS, Thomsen RW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160–167. doi:10.1016/j.rmed.2016.09.00727692139
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30(1):51–59. doi:10.1007/s11606-014-3029-025245885
   PubMed Web of Science ®Google Scholar
• Henoch I, Strang S, Löfdahl C-G, Ekberg-Jansson A. Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis. 2016;11:2681–2690. doi:10.2147/COPD.S11523827822030
   PubMed Web of Science ®Google Scholar
• Landsting S Kvalitetsindikatorer i hälso- och sjukvården; 2012 Available from: www.skl.se/publikationer.
   Google Scholar
• Merlo J, Wagner P, Ghith N, Leckie G. An original stepwise multilevel logistic regression analysis of discriminatory accuracy: the case of neighbourhoods and health. PLoS One. 2016;11(4):e0153778. doi:10.1371/journal.pone.0153778.27120054
   PubMed Web of Science ®Google Scholar
• Merlo J. Invited commentary: multilevel analysis of individual heterogeneity-a fundamental critique of the current probabilistic risk factor epidemiology. Am J Epidemiol. 2014;180(2):208–212. doi:10.1093/aje/kwu10824925064
   PubMed Web of Science ®Google Scholar
• Merlo J. Multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework. Social Sci Med. 2018;203:74–80. doi:10.1016/j.socscimed.2017.12.026
   PubMed Web of Science ®Google Scholar
• Merlo J, Wagner P, Leckie G. A simple multilevel approach for analysing geographical inequalities in public health reports: the case of municipality differences in obesity. Health Place. 2019;58:102145. doi:10.1016/j.healthplace.2019.10214531195211
   PubMed Web of Science ®Google Scholar
• Merlo J. Multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework. Soc Sci Med. 2017;203: 74–80.
   Web of Science ®Google Scholar
• Ludvigsson JF, Almqvist C, Bonamy AK, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125–136.26769609
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-45021658213
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi:10.1002/pds.129416897791
   PubMed Web of Science ®Google Scholar
• Brooke HL, Talback M, Hornblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773. doi:10.1007/s10654-017-0316-128983736
   PubMed Web of Science ®Google Scholar
• Public Access to Information and Secrecy Act: Government Offices of Sweden; 2009 Available from: http://www.government.se/information-material/2009/09/public-access-to-information-and-secrecy-act/.
   Google Scholar
• Galobardes B, Lynch J, Smith GD. Measuring socioeconomic position in health research. Br Med Bull. 2007;81–82(1):21–37. doi:10.1093/bmb/ldm001
   PubMed Web of Science ®Google Scholar
• Jones K, Johnston R, Manley D. Uncovering interactions in multivariate contingency tables: a multi-level modelling exploratory approach. Methodol Innovations. 2016;9:1–17. doi:10.1177/2059799116672874
   Google Scholar
• Evans CR, Williams DR, Onnela J-P, Subramanian S. A multilevel approach to modeling health inequalities at the intersection of multiple social identities. Soc Sci Med. 2017;203:64–73.29199054
   PubMed Web of Science ®Google Scholar
• Goldstein H, Browne WJ, Rashbash J. Partitioning variation in multilevel models. Understanding Stat. 2002;1(4):223–231. doi:10.1207/S15328031US0104_02
   Google Scholar
• Merlo J, Yang M, Chaix B, Lynch J, Rastam L. A brief conceptual tutorial on multilevel analysis in social epidemiology: investigating contextual phenomena in different groups of people. J Epidemiol Community Health. 2005;59(9):729–736. doi:10.1136/jech.2004.02392916100308
   PubMed Web of Science ®Google Scholar
• Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290–297. doi:10.1136/jech.2004.02945416537344
   PubMed Web of Science ®Google Scholar
• Wagner P, Merlo J. Measures of discriminatory accuracy in multilevel analysis. Eur J Epidemiol. 2013;28(1, Supplement):135.
   Google Scholar
• Wagner P, Merlo J. Discriminatory accuracy of a random effect in multilevel logistic regression. Int J Epidemiol. 2014;44(suppl_1):i49–i50. doi:10.1093/ije/dyv097.190
   Google Scholar
• Charlton C, Rasbash J, Browne WJ, Healy M, Cameron B. MLwiN Version 3.00. Centre for Multilevel Modelling, University of Bristol.; 2017.
   Google Scholar
• Leckie G, Charlton C. runmlwin - A program to run the MLwiN multilevel modelling software from within stata. J Stat Softw. 2013;52(11):1–40.23761062
   PubMed Web of Science ®Google Scholar
• Zhang Z, Parker R, Charlton C, Leckie G, Browne WJ. R2MLwiN - A program to run the MLwiN multilevel modelling software from within R. J Stat Softw. 2016;72(10):1–43. doi:10.18637/jss.v072.i10
   Web of Science ®Google Scholar
• Leckie G, Charlton C. runmlwin - A program to run the MLwiN multilevel modelling software from within stata. J Stat Softw. 2013;52(11):1–40. doi:10.18637/jss.v052.i1223761062
   PubMed Web of Science ®Google Scholar
• Browne WJ MCMC estimation in MLwiN. Version 2.31. Centre for multilevel modelling, university of Bristol. 2014; ISBN: 978-0-903024-99-0Available from: http://www.bristol.ac.uk/cmm/media/migrated/2-31/mcmc-print.pdf.
   Google Scholar
• Lange P, Tottenborg SS, Sorknaes AD, et al. Danish Register of chronic obstructive pulmonary disease. Clin Epidemiol. 2016;8:673–678. doi:10.2147/clep.s99489;.27822114
   PubMed Web of Science ®Google Scholar
• Hjerpe P, Ohlsson H, Lindblad U, Bostrom KB, Merlo J. Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database. Eur J Clin Pharmacol. 2010;67:415–423.21190018
   PubMed Web of Science ®Google Scholar
• Ohlsson H, Lindblad U, Lithman T, et al. Understanding adherence to official guidelines on statin prescribing in primary health care - a multi-level methodological approach. Eur J Clin Pharmacol. 2005;61(9):657–665. doi:10.1007/s00228-005-0975-916133551
   PubMed Web of Science ®Google Scholar
• Sundh J, Aberg J, Hasselgren M, et al. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir j. 2017;4(1):1409060. doi:10.1080/20018525.2017.140906029230274
   PubMed Web of Science ®Google Scholar
• Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008;30(5):509–514. doi:10.1007/s11096-008-9197-418247154
   PubMed Web of Science ®Google Scholar
• Luftvägsregistret; 2017 Available from: https://lvr.registercentrum.se/om-registret/om-luftvagsregistret/p/BJGNnV3Zl2017.
   Google Scholar
• Sator L, Horner A, Studnicka M, et al. Overdiagnosis of COPD in subjects with unobstructed spirometry: A BOLD Analysis. Chest. 2019;156(2):277–288. doi:10.1016/j.chest.2019.01.01530711480
   PubMed Web of Science ®Google Scholar
• Gershon AS, Thiruchelvam D, Chapman KR, et al. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153(6):1336–1346. doi:10.1016/j.chest.2018.01.03829425675
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Vestbo J, et al. Characteristics of undertreatment in COPD in the general population. Chest. 2013;144(6):1811–1818. doi:10.1378/chest.13-045323989916
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006;7(1):52. doi:10.1186/1465-9921-7-5216571126
   PubMed Web of Science ®Google Scholar
• Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480–485. doi:10.1136/thx.2009.12200220522842
   PubMed Web of Science ®Google Scholar
• Vilhelmsson A, Ostergren PO. Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education - A rapid review. PLoS One. 2018;13(4):e0195774. doi:10.1371/journal.pone.0195774.29659598
   PubMed Web of Science ®Google Scholar
• Axelsson Fisk S, Mulinari S, Wemrell M, et al. Chronic obstructive pulmonary disease in sweden: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy. SSM Popul Health. 2018;4:334–346. doi:10.1016/j.ssmph.2018.03.00529854918
   PubMed Web of Science ®Google Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med;2018:18(1); 163. doi:10.1186/s12890-018-0724-330340565
   PubMed Web of Science ®Google Scholar
• Koehorst-ter Huurne K, Movig K, van der Valk P, et al. The influence of type of inhalation device on adherence of COPD patients to inhaled medication. Expert Opin Drug Deliv. 2016;13(4):469–475. doi:10.1517/17425247.2016.113069526666841
   PubMed Web of Science ®Google Scholar
• Inghammar M, Engstrom G, Lofdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health. 2012;40(8):773–776. doi:10.1177/1403494812463172.23085721
   PubMed Web of Science ®Google Scholar
• Merlo J. Multilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of association. J Epidemiol Community Health. 2003;57(8):550–552. (). doi:10.1136/jech.57.8.55012883048
   PubMed Web of Science ®Google Scholar
• Ghith N, Frolich A, Merlo J. The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes. PLoS One. 2017;12(12):e0189050. doi:10.1371/journal.pone.018905029211785
   PubMed Web of Science ®Google Scholar
• Merlo J, Mulinari S, Wemrell M, Subramanian SV, Hedblad B. The tyranny of the averages and the indiscriminate use of risk factors in public health: the case of coronary heart disease. SSM Popul Health. 2017;3:684–698. doi:10.1016/j.ssmph.2017.08.00529349257
   PubMed Web of Science ®Google Scholar
• Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 1 ed. Thousand Oaks, California: SAGE Publications; 1999.
   Google Scholar
• Hox JJ. Multilevel Analysis: Techniques and Applications. 2nd ed. New York: Routledge; 2010:382.
   Google Scholar
• Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. Second ed. Newbury Park, CA: Sage; 2002.
   Google Scholar
• Goldstein H, Goldstein H. Multilevel Statistical Models. 2nd ed. London: E. Arnold; 1995.
   Google Scholar
• Merlo J, Chaix B, Yang M, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon. J Epidemiol Community Health. 2005;59(6):443–449. doi:10.1136/jech.2004.02347315911637
   PubMed Web of Science ®Google Scholar
• Merlo J, Chaix B, Yang M, et al. A brief conceptual tutorial on multilevel analysis in social epidemiology: interpreting neighbourhood differences and the effect of neighbourhood characteristics on individual health. J Epidemiol Community Health. 2005;59(12):1022–1028. doi:10.1136/jech.2004.02803516286487
   PubMed Web of Science ®Google Scholar
• Marmot M, Bell R. Fair society, healthy lives. Public Health. 2012;126 Suppl 1:S4–s10. doi:10.1016/j.puhe.2012.05.01422784581
   PubMed Web of Science ®Google Scholar
• Carey G, Crammond B, De Leeuw E. Towards health equity: a framework for the application of proportionate universalism. Int J Equity Health. 2015;14(1):81. (). doi:10.1186/s12939-015-0207-626369339
   PubMed Web of Science ®Google Scholar
• Tottenborg SS, Lange P, Thomsen RW, Nielsen H, Johnsen SP. Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative. Respir Med. 2017;125:19–23. doi:10.1016/j.rmed.2017.02.01628340857
   PubMed Web of Science ®Google Scholar